Detalles de la búsqueda
1.
Determining optimal prostate-specific antigen thresholds to identify an increased 4-year risk of prostate cancer development: an analysis within the Veterans Affairs Health Care System.
World J Urol
; 34(8): 1107-13, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26753559
2.
Early symptom improvement and discontinuation of 5-α-reductase inhibitor (5ARI) therapy in patients with benign prostatic hyperplasia (BPH).
Ann Pharmacother
; 48(3): 343-8, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24311727
3.
Clinical and economic impact of early versus delayed 5-alpha reductase inhibitor therapy in men taking alpha blockers for symptomatic benign prostatic hyperplasia.
P T
; 36(8): 493-507, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21935297
4.
An assessment of the diagnosed prevalence of diseases in men 50 years of age or older.
Am J Manag Care
; 12(4 Suppl): S83-9, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16551206
5.
Anxiety disorders in the 21st century: status, challenges, opportunities, and comorbidity with depression.
Am J Manag Care
; 11(12 Suppl): S344-53, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16236016
6.
Cost-minimization analysis of darbepoetin alfa versus epoetin alfa in the hospital setting.
Am J Health Syst Pharm
; 62(24): 2597-603, 2005 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16333057
7.
Evaluation of recent trends in treatment patterns among men with benign prostatic hyperplasia.
Am J Mens Health
; 7(3): 214-9, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23221685
8.
Establishing the clinical and economic benefits of adherence to 5-alpha reductase inhibitors in benign prostatic hyperplasia: an assessment of Medicare and Medicaid patients.
Expert Opin Pharmacother
; 13(18): 2593-600, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23163741
9.
The economic impact of delaying 5-alpha reductase inhibitor therapy in men receiving treatment for symptomatic benign prostatic hyperplasia.
Am Health Drug Benefits
; 4(3): 155-62, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25126348
10.
Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery.
Curr Med Res Opin
; 25(11): 2663-9, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19757985
11.
Cost comparison of finasteride and dutasteride for enlarged prostate in a managed care setting among Medicare-aged men.
Am J Manag Care
; 14(5 Suppl 2): S167-71, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18611091
Resultados
1 -
11
de 11
1
Próxima >
>>